Clinical trial of the effects of coenzyme Q10 supplementation on glycemic control and markers of lipid profiles in diabetic hemodialysis patients

ConclusionsOverall, our study supported that CoQ10 supplementation to diabetic HD patients for 12 weeks had beneficial effects on markers of insulin metabolism, but did not affect fasting glucose, HbA1c, and lipid profiles.Clinical registrationhttp://www.irct.ir: IRCT2016081811763N30.
Source: International Urology and Nephrology - Category: Urology & Nephrology Source Type: research